Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Mohsan Saeed
Affiliation
Boston University Chobanian and Avedisian School of Medicine
ORCID
Career Start Year
2007
Papers
59
H Index
24
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36263066
Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1 Omicron.
bioRxiv
2023
37664626
Plant flavonoid inhibition of SARS-CoV-2 main protease and viral replication.
iScience
2023
37499664
High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface.
Cell Chem Biol
2023
37534130
Isogenic human trophectoderm cells demonstrate the role of <i>NDUFA4</i> and associated variants in ZIKV infection.
iScience
2023
37477426
SARS-CoV-2 nonstructural protein 6 from Alpha to Omicron: evolution of a transmembrane protein.
mBio
2023
37398281
The HLA-II immunopeptidome of SARS-CoV-2.
bioRxiv
2023
37095858
Cell culture systems for isolation of SARS-CoV-2 clinical isolates and generation of recombinant virus.
iScience
2023
36630998
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation.
Nature
2023
34668773
Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.
J Virol
2022
35367208
Proteomic elucidation of the targets and primary functions of the picornavirus 2A protease.
J Biol Chem
2022
35631043
Surgical Strikes on Host Defenses: Role of the Viral Protease Activity in Innate Immune Antagonism.
Pathogens
2022
35421379
Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection.
Cell Rep
2022
36475798
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo.
Sci Adv
2022
36595954
HLA-I immunopeptidome profiling of human cells infected with high-containment enveloped viruses.
STAR Protoc
2022
36206731
A human iPSC-array-based GWAS identifies a virus susceptibility locus in the NDUFA4 gene and functional variants.
Cell Stem Cell
2022
35336942
Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression.
Viruses
2022
33469581
Fatal neuroinvasion and SARS-CoV-2 tropism in K18-hACE2 mice is partially independent on hACE2 expression.
bioRxiv
2021
33686143
The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication.
Sci Rep
2021
33548599
Detecting SARS-CoV-2 3CLpro expression and activity using a polyclonal antiserum and a luciferase-based biosensor.
Virology
2021
33851170
Drug repositioning candidates identified using in-silico quasi-quantum molecular simulation demonstrate reduced COVID-19 mortality in 1.5M patient records.
medRxiv
2021
33890572
SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation.
Elife
2021
34379400
Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins.
ACS Appl Mater Interfaces
2021
34405680
Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants.
J Med Chem
2021
33989385
DNA templates with blocked long 3' end single-stranded overhangs (BL3SSO) promote bona fide Cas9-stimulated homology-directed repair of long transgenes into endogenous gene loci.
G3 (Bethesda)
2021
34013166
Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins.
ChemRxiv
2021
34260266
SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway.
J Virol
2021
33417854
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2.
Mol Cell
2021
32321830
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody.
Proc Natl Acad Sci U S A
2020
33140044
SARS-CoV-2 desensitizes host cells to interferon through inhibition of the JAK-STAT pathway.
bioRxiv
2020
33024965
SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs.
bioRxiv
2020
33148654
Liver-expressed <i>Cd302</i> and <i>Cr1l</i> limit hepatitis C virus cross-species transmission to mice.
Sci Adv
2020
33259812
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2.
Mol Cell
2020
32637964
SARS-CoV-2 Infection of Pluripotent Stem Cell-derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.
bioRxiv
2020
32997711
Defining the proteolytic landscape during enterovirus infection.
PLoS Pathog
2020
32826914
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.
Nat Commun
2020
32704094
LY6E impairs coronavirus fusion and confers immune control of viral disease.
Nat Microbiol
2020
32979316
SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.
Cell Stem Cell
2020
32245952
Stem cell-derived polarized hepatocytes.
Nat Commun
2020
30875640
Taming a beast: lessons from the domestication of hepatitis C virus.
Curr Opin Virol
2019
31717338
Visualization of Positive and Negative Sense Viral RNA for Probing the Mechanism of Direct-Acting Antivirals against Hepatitis C Virus.
Viruses
2019
30355490
NS5A Promotes Constitutive Degradation of IP3R3 to Counteract Apoptosis Induced by Hepatitis C Virus.
Cell Rep
2018
29844387
Male germ cells support long-term propagation of Zika virus.
Nat Commun
2018
30403995
A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates.
Cell Rep
2018
30478404
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication.
Sci Rep
2018
28475892
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.
Cell
2017
28112725
Erratum: Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture.
Nat Microbiol
2017
27991882
Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture.
Nat Microbiol
2016
25714714
Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4.
mBio
2015
26266980
SEC14L2 enables pan-genotype HCV replication in cell culture.
Nature
2015
24362933
Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection.
Nat Med
2014
1 - 50 of 59
Column Actions
Search
Recommended Authors
Mir M Khalid
Gladstone Institutes
Career Start Year
2016
Number of shared co-authors
0
Stuart Weston
University of Maryland School of Medicine
Career Start Year
2014
Number of shared co-authors
2
Andreas S Puschnik
Stanford University School of Medicine
Career Start Year
2013
Number of shared co-authors
0
Hongjie Xia
University of Texas Medical Branch
Career Start Year
2012
Number of shared co-authors
0
Xin Yin
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2010
Number of shared co-authors
0
Craig B Wilen
Yale School of Medicine
Career Start Year
2010
Number of shared co-authors
2
Siyuan Ding
Washington University School of Medicine
Career Start Year
2009
Number of shared co-authors
0
Holly Ramage
Sidney Kimmel Medical College, Thomas Jefferson University
Career Start Year
2009
Number of shared co-authors
0
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Career Start Year
2008
Number of shared co-authors
2
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year
2008
Number of shared co-authors
3
Vineet D Menachery
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
0
Nicholas S Heaton
Duke University School of Medicine
Career Start Year
2006
Number of shared co-authors
3
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year
2005
Number of shared co-authors
0
Marek Widera
Goethe University Frankfurt, University Hospital, Institute for Medical Virology
Career Start Year
2004
Number of shared co-authors
0
Rachel L Graham
University of North Carolina
Career Start Year
2004
Number of shared co-authors
0
Yaw Shin Ooi
Duke-NUS Medical School
Career Start Year
2003
Number of shared co-authors
0
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Career Start Year
2003
Number of shared co-authors
2
Shirit Einav
Stanford University School of Medicine
Career Start Year
2002
Number of shared co-authors
0
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year
2001
Number of shared co-authors
3
Amy C Sims
The University of North Carolina at Chapel Hill
Career Start Year
1998
Number of shared co-authors
0
Pei-Yong Shi
University of Texas Medical Branch
Career Start Year
1996
Number of shared co-authors
3
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year
1995
Number of shared co-authors
3
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
1993
Number of shared co-authors
4
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
0
Brett D Lindenbach
Yale University School of Medicine
Career Start Year
1993
Number of shared co-authors
3
Lucy Thorne
University College London
Career Start Year
1992
Number of shared co-authors
1
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
1988
Number of shared co-authors
5
Arvind H Patel
MRC-University of Glasgow Centre for Virus Research
Career Start Year
1987
Number of shared co-authors
1
Bart L Haagmans
Erasmus Medical Center
Career Start Year
1986
Number of shared co-authors
1
Ralph S Baric
University of North Carolina
Career Start Year
1981
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Charles M Rice
Rockefeller University
Co-authored papers
25
Andrew Emili
Boston University School of Medicine, Boston University
Co-authored papers
6
Elke Mühlberger
Co-authored papers
4
Ellen L Suder
Co-authored papers
4
Pamela J Bjorkman
Co-authored papers
3
Pardis C Sabeti
Harvard University
Co-authored papers
3
Steven A Carr
Broad Institute of MIT and Harvard
Co-authored papers
3
Karl R Clauser
Co-authored papers
2
Celia A Schiffer
University of Massachusetts Chan Medical School
Co-authored papers
2
Ulrich Braunschweig
University of Toronto
Co-authored papers
2
Dima Kozakov
Stony Brook University
Co-authored papers
2
Sadhna Phanse
University of Regina
Co-authored papers
2
Dzmitry Padhorny
Co-authored papers
2
Hans-Heinrich Hoffmann
The Rockefeller University
Co-authored papers
2
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Co-authored papers
2
Stefan Wuchty
University of Miami
Co-authored papers
2
Benjamin J Blencowe
University of Toronto
Co-authored papers
2
Qibin Qi
Co-authored papers
2
Thiago Y Oliveira
The Rockefeller University
Co-authored papers
2
Nir Hacohen
Broad Institute of MIT and Harvard
Co-authored papers
2
Henrik Molina
Co-authored papers
2
Michael Ott
Co-authored papers
1
Erica Y Jacobs
The Rockefeller University, St John's University
Co-authored papers
1
George M Shaw
Co-authored papers
1
Kenneth Gersing
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers
1
Peter C Fridy
The Rockefeller University
Co-authored papers
1
Albert I Ko
Instituto Goncalo Moniz, Yale School of Public Health
Co-authored papers
1
Christopher G Chute
Brown University, Brown University Warren Alpert Medical School, Dartmouth-Hitchcock Medical Center, Harvard School of Public Health, Johns Hopkins Medicine, Mayo Clinic Minnesota
Co-authored papers
1
Maxwell L Neal
Co-authored papers
1
M Ruhul Abid
Brown University.
Co-authored papers
1
1 - 30